FACTOR XA INHIBITOR
Clinical trials for FACTOR XA INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new FACTOR XA INHIBITOR trials appear
Sign up with your email to follow new studies for FACTOR XA INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial could unlock lifesaving stroke treatment for thousands on blood thinners
Disease control Recruiting nowThis study tests whether stroke patients who take blood thinners (FXa inhibitors) can safely receive a standard clot-busting drug (IVT). Current guidelines deny IVT to these patients due to bleeding fears, but new evidence suggests it may be safe. The trial will compare recovery …
Matched conditions: FACTOR XA INHIBITOR
Phase: PHASE3 • Sponsor: Guri Hagberg • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
New study tracks emergency bleeding reversal drug in Real-World use
Disease control Recruiting nowThis study monitors the safety and effectiveness of Ondexxya, a drug used to reverse the effects of certain blood thinners (apixaban, rivaroxaban, or edoxaban) during life-threatening or unstoppable bleeding. Researchers will track side effects and how well the drug works in 300 …
Matched conditions: FACTOR XA INHIBITOR
Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC